No Time to Die: Living Better, Not Just Longer

Can Science Help Us Live Better — Not Just Longer? In a world where life expectancy has doubled in a century, a curious contradiction persists: we are living longer, but not necessarily better. For many, the final decades of life are marked not by adventure or purpose but by frailty, pain, or cognitive decline. Dhruv Khullar’s No Time to Die explores a quiet revolution in medicine—one that seeks not merely to extend lifespan but to expand healthspan: the number of years we live free of serious disease or disability.

This isn’t about immortality. It’s about redefining aging. What if we could slow the biological clock just enough to delay arthritis, dementia, or cancer? What if a person’s seventies could feel more like their fifties? This vision, once speculative, now drives research in genetics, metabolism, and regenerative medicine—with billions of dollars at stake and growing urgency as populations age.

Yet the pursuit of healthspan raises deeper questions—about equity, meaning, and what it truly means to live well. As with most scientific breakthroughs, benefits may not be distributed evenly. The debate between “more years” and “better years” is also a debate about who gets to live those better years—and at what cost to the collective good.

The Biology of Possibility

Scientists increasingly see aging not as inevitable decline but as a modifiable biological process. The slow accumulation of cellular damage—through oxidative stress, inflammation, and DNA replication errors—contributes to nearly every chronic condition associated with age. If we can interrupt or repair those pathways, we could delay not just one disease but many at once.

Khullar introduces readers to researchers studying senolytics—drugs that clear out “zombie cells” that refuse to die—and to teams exploring the cellular molecule NAD+, which declines with age and may hold the key to metabolic vitality. Others investigate the mTOR pathway, targeted by the drug rapamycin, long known to extend life in animals. Even lifestyle interventions—intermittent fasting, cold exposure, high-intensity exercise—are being reconsidered as molecular levers of longevity.

But the excitement carries caveats. Small studies often make big headlines. Animal models don’t always predict human outcomes. And the line between realistic hope and hype can blur when venture capital enters the lab. As Khullar reminds us, biological potential always unfolds within social and ethical boundaries.

A Race Against Time—and Inequality

The longevity frontier is as economic as it is scientific. Some of the boldest experiments in healthspan are funded by the ultra-wealthy—tech billionaires investing in “moonshots” to defeat aging. These projects often promise public benefit but remain accessible, at least initially, only to those who can pay.

That dynamic risks deepening inequality. If a privileged few gain access to therapies that delay decline by decades, disparities in health, wealth, and opportunity could widen dramatically. Extended vitality for some could mean extended precarity for others. The workforce, the pension system, and healthcare budgets would all strain under new pressures unless policy keeps pace with biology.

Public-health experts argue that the greatest gains still come from the basics: clean air, good food, safe housing, and social connection. A pill that adds ten healthy years might make headlines—but a community that nurtures belonging may add more quality to life than any molecule ever could.

From Lifespan to Purpose-span

The most profound questions are philosophical. If we can extend the number of healthy years people live, what do we do with that time?

Society’s systems—from retirement plans to higher education—were designed for shorter lives. If humans regularly reach their nineties in vigor, we’ll need to rethink education as a lifelong pursuit, careers as multi-chapter narratives, and caregiving as a shared responsibility across generations.

Equally vital is how individuals find purpose in longevity. Research consistently links meaning and community engagement with better health outcomes. Without social imagination, extended healthspans could devolve into longer periods of isolation or boredom. To live longer well, we must cultivate not only medicine but meaning.

Interconnections Everywhere

At its core, the quest to extend healthspan illuminates how intertwined our systems are—biological, economic, and ethical. A molecule that slows cellular aging reshapes city planning, social policy, and even intergenerational contracts. It changes how we define “old age,” how families organize care, and what societies value.

Yet progress in one domain without balance in others creates fragility. Longer lives without equitable access, purpose, or belonging risk becoming burdens rather than blessings. True longevity must be shared, sustainable, and soulful.

Historical Lens: 25 Years of Longevity Science

A generation ago, the dream of slowing aging was fringe science. In the early 2000s, caloric restriction dominated the field: studies in mice and monkeys showed that fewer calories could extend lifespan. By the 2010s, attention turned to molecular pathways like sirtuins and mTOR, unlocking mechanisms once thought mysterious. The discovery of Yamanaka factors—genes capable of reprogramming adult cells to youthful states—expanded the frontier again.

More recently, CRISPR gene editing and single-cell sequencing have accelerated our grasp of aging at the genomic level. Trials with senolytics and rapamycin analogs are now testing in humans what once seemed myth. But as tools sharpen, the ethical horizon widens. Who decides how far to push rejuvenation? What happens to generational balance when eighty-year-olds remain as vital as fifty-year-olds?

History shows that longevity science evolves in lockstep with cultural readiness. Each leap in biology requires an equal leap in empathy and governance. The last twenty-five years of discovery remind us: slowing time in the body means reimagining time in society.

Sidebar: The Ripple Effects of Healthier Longevity

• Healthcare: Prevention and maintenance over crisis response; new models of geriatric and community care. • Work & Retirement: Longer careers may demand midlife retooling and multiple “acts” in a life story. • Housing & Infrastructure: Accessible, intergenerational neighborhoods that adapt to fluid family structures. • Family Structure: Shared caregiving and extended kinship networks redefining inheritance and support. • Social Policy: Fair access to treatments, universal design, and the ethics of aging well together.

We are not just adding years — we are changing the shape of life itself.

Classroom Discussion Prompts

• What do you think matters more: lifespan or healthspan? Why? • Should society invest in extending human healthspans—and who should benefit? • How might longer, healthier lives transform work, retirement, or education? • What ethical risks arise if longevity treatments remain accessible only to the wealthy? • If you could live to 100 in good health, how would you want to use those extra decades?

Sources

• Dhruv Khullar, “No Time to Die,” The New Yorker, April 22 & 29, 2024. Primary source of inspiration; explores the scientific, ethical, and social dimensions of healthspan research. • National Institute on Aging, “Understanding the Dynamics of Aging.” Overview of biological processes—oxidative stress, senescence, DNA repair—underpinning modern longevity science. • Matt Kaeberlein et al., “Rapamycin and the Biology of Aging,” Science, 2019. Key summary of the mTOR pathway and lifespan extension mechanisms. • David Sinclair, Lifespan: Why We Age—and Why We Don’t Have To (Atria, 2019). Provides context on sirtuins, NAD+, and molecular rejuvenation strategies. • World Health Organization, “Decade of Healthy Ageing (2021–2030).” Connects biological longevity with global policy and social equity frameworks. • Eileen Ailshire & Eileen Crimmins, “Psychosocial Factors and Healthy Aging,” Annual Review of Gerontology and Geriatrics, 2011. Establishes empirical links between meaning, engagement, and physical health.

© 2025 Michael A. Pink